Kathrin Kastenmüller

In vivo characterization of the physicochemical properties of polymer-linked TLR agonists that enhance vaccine immunogenicity

Geoffrey M. Lynn, Richard Laga, Patricia A. Darrah et al. · Nature Biotechnology · 2015 · 428 citations · Full text

Vaccination, Mucosal Vaccination, Allergy +11

Protective T cell immunity in mice following protein-TLR7/8 agonist-conjugate immunization requires aggregation, type I IFN, and multiple DC subsets

Kathrin Kastenmüller, Ulrike Wille-Reece, Ross Lindsay et al. · Journal of Clinical Investigation · 2011 · 164 citations · Full text

Adaptive Immune System, Dc Subsets, T-regulatory Cell +19

Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates

Barbara J. Flynn, Kathrin Kastenmüller, Ulrike Wille-Reece et al. · Proceedings of the National Academy of Sciences · 2011 · 127 citations · Full text

Antigen expression determines adenoviral vaccine potency independent of IFN and STING signaling

Kylie M. Quinn, Daniel E. Zak, Andréia da Silva Costa et al. · Journal of Clinical Investigation · 2015 · 110 citations · Full text

Adaptive Immune System, Immunology, Adenoviral Vaccine Potency +24

Full-Length Plasmodium falciparum Circumsporozoite Protein Administered with Long-Chain Poly(I·C) or the Toll-Like Receptor 4 Agonist Glucopyranosyl Lipid Adjuvant-Stable Emulsion Elicits Potent Antibody and CD4⁺T Cell Immunity and Protection in Mice

Kathrin Kastenmüller, Diego A. Espinosa, Lauren Trager et al. · Infection and Immunity · 2012 · 77 citations · Full text